Company has posted a loss of Rs 39.72 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
Astec Lifesciences Share Price
Astec Lifesciences Shar...
Astec Lifesc share price insights
Stock gave a 3 year return of -9.38% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company witnessed QoQ revenue decline of 54.88%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Company has spent 5.51% of its operating revenues towards interest expenses and 13.48% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Astec Lifesciences Ltd. share price moved down by -1.01% from its previous close of Rs 1,213.10. Astec Lifesciences Ltd. stock last traded price is 1,200.85
Share Price Value Today/Current/Last 1,200.85 Previous Day 1,213.10
Key Metrics
PE Ratio (x) | -30.01 | ||||||||||
EPS - TTM (₹) | -40.01 | ||||||||||
MCap (₹ Cr.) | 2,354.90 | ||||||||||
Sectoral MCap Rank | 14 | ||||||||||
PB Ratio (x) | 6.44 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.20 | ||||||||||
VWAP (₹) | 1,202.52 | ||||||||||
52W H/L (₹) |
Astec Lifesc Share Price Returns
1 Day | -1.01% |
1 Week | -3.41% |
1 Month | -5.22% |
3 Months | 7.88% |
1 Year | -14.84% |
3 Years | -9.38% |
5 Years | 220.14% |
Astec Lifesc News & Analysis
Astec Lifesc Share Recommendations
Recent Recos
Current
Mean Recos by 1 Analysts
SellSellHoldBuyStrong
Buy
That's all for Astec Lifesc recommendations. Check out other stock recos.
Analyst Trends
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 |
Buy | - | - | - | - |
Hold | - | - | - | - |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 1 | 1 | 1 | 1 |
Astec Lifesc Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
PAT: Troublesome Times
Company has posted a loss of Rs 39.72 cr for the 4th consecutive quarter. (Source: Consolidated Financials)Quarterly Topline Performance
Company witnessed QoQ revenue decline of 54.88%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 70.30 155.80 51.70 111.77 144.56 Total Income Growth (%) -54.88 201.32 -53.74 -22.68 11.59 Total Expenses 124.89 150.05 77.83 123.37 149.10 Total Expenses Growth (%) -16.76 92.79 -36.91 -17.26 15.29 EBIT -54.60 5.75 -26.12 -11.60 -4.54 EBIT Growth (%) -1,049.69 - - - -2,212.78 Profit after Tax (PAT) -39.72 -0.97 -24.33 -13.43 -8.19 PAT Growth (%) - - - - - EBIT Margin (%) -77.67 3.69 -50.53 -10.38 -3.14 Net Profit Margin (%) -56.51 -0.63 -47.06 -12.01 -5.67 Basic EPS (₹) -20.26 -0.50 -12.41 -6.85 -4.18 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 974.93 979.41 896.76 677.59 571.72 Total Assets Growth (%) -0.46 9.22 32.35 18.52 23.99 Total Liabilities 605.41 559.86 500.10 368.27 324.82 Total Liabilities Growth (%) 8.14 11.95 35.80 13.37 25.76 Total Equity 369.52 419.56 396.66 309.32 246.89 Total Equity Growth (%) -11.93 5.77 28.24 25.28 21.74 Current Ratio (x) 1.00 0.95 1.05 1.03 1.04 Total Debt to Equity (x) 1.34 0.81 0.70 0.60 0.40 Contingent Liabilities 213.66 256.17 239.82 233.75 274.87 All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 135.18 cr for investing activities which is an YoY increase of 20.15%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 10.22 74.66 23.60 -8.16 168.44 Net Cash used in Investing Activities -135.18 -112.51 -103.87 -73.11 -73.81 Net Cash flow from Financing Activities 124.96 37.77 80.48 81.34 -94.53 Net Cash Flow 0.00 -0.08 0.22 0.06 0.10 Closing Cash & Cash Equivalent 0.47 0.47 0.55 0.37 0.31 Closing Cash & Cash Equivalent Growth (%) -0.40 -14.63 48.86 20.90 45.12 Total Debt/ CFO (x) 48.32 4.57 11.84 -22.91 0.59 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) -12.70 6.09 22.66 21.03 19.26 Return on Capital Employed (%) -6.32 12.28 32.05 26.40 29.18 Return on Assets (%) -4.81 2.61 10.02 9.60 8.31 Interest Coverage Ratio (x) -0.01 4.31 18.17 19.75 5.87 Asset Turnover Ratio (x) 0.47 0.67 0.86 81.88 91.40 Price to Earnings (x) -44.44 106.38 38.31 30.21 16.47 Price to Book (x) 5.64 6.46 8.66 6.34 3.17 EV/EBITDA (x) -9,580.53 34.14 22.56 17.95 9.06 EBITDA Margin (%) -0.05 14.21 24.31 21.53 18.58
Astec Lifesc Peer Comparison
Astec Lifesc Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -9.38% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -9.38% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
See All Parameters
MF Ownership
56.55
Amount Invested (in Cr.)
0.09%
% of AUM
0.00
% Change (MoM basis)
20.98
Amount Invested (in Cr.)
1.0%
% of AUM
100.00
% Change (MoM basis)
ICICI Pru Commodities Direct-G
Equity: Thematic
13.56
Amount Invested (in Cr.)
0.52%
% of AUM
0.00
% Change (MoM basis)
MF Ownership as on 31 July 2024
Corporate Actions
Astec Lifesc Board Meeting/AGM
Astec Lifesc Dividends
- Others
Meeting Date Announced on Purpose Details Jul 29, 2024 Jul 18, 2024 Board Meeting Quarterly Results May 02, 2024 Apr 24, 2024 Board Meeting Audited Results Mar 10, 2024 Feb 07, 2024 POM - Jan 25, 2024 Jan 12, 2024 Board Meeting Quarterly Results Oct 27, 2023 Oct 10, 2023 Board Meeting Quarterly Results & Others Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 15% 1.5 Jul 21, 2023 May 02, 2023 Final 15% 1.5 Jul 19, 2022 May 02, 2022 Final 15% 1.5 Jul 22, 2021 Apr 30, 2021 Final 15% 1.5 Jul 16, 2020 May 05, 2020 Final 15% 1.5 Jul 18, 2019 Apr 30, 2019 No other corporate actions details are available.
About Astec Lifesc
Astec Lifesciences Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 2,354.90 Crore) operating in Pesticides/Agro Chemicals sector. Astec Lifesciences Ltd. key Products/Revenue Segments include Agrochemicals, Other Operating Revenue for the year ending 31-Mar-2024. Show More
Executives
Auditors
- NB
Nadir B Godrej
ChairmanAVAshok V Hiremath
Non Executive DirectorBSBalram Singh Yadav
Non Executive DirectorBNBurjis Nadir Godrej
Non Executive DirectorShow More - BSR & Co. LLP
Industry
Key Indices Listed on
BSE SmallCap, BSE Commodities, BSE AllCap, + 1 more
Address
Godrej One, 3rd Floor,Pirojshanagar,Eastern Express Highway,Mumbai, Maharashtra - 400079
More Details
FAQs about Astec Lifesc share
- 1. What's Astec Lifesc share price today and what are Astec Lifesc share returns ?As on 29 Aug, 2024, 03:55 PM IST Astec Lifesc share price was down by 1.01% basis the previous closing price of Rs 1,221.25. Astec Lifesc share price was Rs 1,200.85. Return Performance of Astec Lifesc Shares:
- 1 Week: Astec Lifesc share price moved down by 3.41%
- 3 Month: Astec Lifesc share price moved up by 7.88%
- 6 Month: Astec Lifesc share price moved up by 34.96%
- 2. What is the market cap of Astec Lifesc?Astec Lifesc share has a market capitalization of Rs 2,354.90 Cr. Within Pesticides/Agro Chemicals sector, it's market cap rank is 14.
- 3. What is the CAGR of Astec Lifesc?The CAGR of Astec Lifesc is -4.67.
- 4. What is 52 week high/low of Astec Lifesc share price?Astec Lifesc share price saw a 52 week high of Rs 1,474.40 and 52 week low of Rs 825.05.
- 5. What are the returns for Astec Lifesc share?Return Performance of Astec Lifesc Shares:
- 1 Week: Astec Lifesc share price moved down by 3.41%
- 3 Month: Astec Lifesc share price moved up by 7.88%
- 6 Month: Astec Lifesc share price moved up by 34.96%
- 6. Who is the chairman of Astec Lifesc?Nadir B Godrej is the Chairman of Astec Lifesc
- 7. What are the Astec Lifesc quarterly results?On Consoldiated basis, Astec Lifesc reported a total income and loss of Rs 70.30 Cr and Rs -39.72 respectively for quarter ending 2024-06-30. Total Income and loss for the year ending 2024-03-31 was Rs 463.82 Cr and Rs -46.93 Cr.
- 8. Who are peers to compare Astec Lifesc share price?Top 10 Peers for Astec Lifesc are India Pesticides Ltd., Insecticides (India) Ltd., Excel Industries Ltd., Heranba Industries Ltd., Punjab Chemicals and Crop Protection Ltd., NACL Industries Ltd., Shivalik Rasayan Ltd., Bhagiradha Chemicals & Industries Ltd., Bharat Rasayan Ltd. and Sharda Cropchem Ltd.
- 9. Is Astec Lifesc giving dividend?Astec Lifesciences Ltd. announced an equity dividend of 15% on a face value of 10.0 amounting to Rs 1.5 per share on 02 May 2023. The ex dividend date was 21 Jul 2023.
- 10. What is the PE & PB ratio of Astec Lifesc?The PE ratio of Astec Lifesc stands at -30.32, while the PB ratio is 6.44.
- 11. How can I quickly analyze Astec Lifesc stock?Key Metrics for Astec Lifesc are:
- PE Ratio of Astec Lifesc is -30.01
- Price/Sales ratio of Astec Lifesc is 4.55
- Price to Book ratio of Astec Lifesc is 6.44
- 12. Who are the key owners of Astec Lifesc stock?
- Promoter holding has not changed in last 9 months and holds 66.75 stake as on 30 Jun 2024
- Domestic Institutional Investors holding have gone down from 10.16 (30 Sep 2023) to 3.37 (30 Jun 2024)
- Foreign Institutional Investors holding have gone down from 1.33 (30 Sep 2023) to 1.03 (30 Jun 2024)
- Other investor holding has gone up from 21.76 (30 Sep 2023) to 28.84 (30 Jun 2024)
Trending in Markets
Astec Lifesc Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.